Transcarent has raised $58m from Bayer and Merck, while Nvidia has bought DeepMap, one of its portfolio companies also backed by Bosch.
Funding US-based consumer-focused healthcare platform operator Transcarent has raised $58m in a series B round featuring Leaps by Bayer and Merck Global Health Innovation Fund, respective vehicles for pharmaceutical group Bayer and Merck, and co-led by 7wire Ventures and General Catalyst. The round also attracted Kleiner Perkins, GreatPoint Ventures, Threshold Ventures, Alta Partners and Jove…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.